Patent Assignment
Reel/Frame 040933/0776
Assignment of Assignor's Interest
Recorded: 2017-01-10
Pages: 3
Assignor
SRX CARDIO, LLC
Executed: 2016-12-30
Assignee
PORTOLA PHARMACEUTICALS, INC.
270 E. GRAND AVE., SUITE 22, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties
(2)
Composition and Methods of Use of Novel Phenylalanine Small Organic Compounds to Directly Modulate Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Protein Activity
Application:
62/298,852 →
Composition and Methods of Use of Phenylpiperazine Compounds that Bind and Modulate Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Activity
Application:
62/298,890 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 3, 2016
From: BARTA, THOMAS E.; BOURNE, JONATHAN W.; MONROE, KYLE D.; MUEHLEMANN, MICHAEL M.
To: SRX CARDIO, LLC
Reel/Frame 038448/0458 →
Assignment of Assignor's Interest
May 3, 2016
From: BARTA, THOMAS E.; BOURNE, JONATHAN W.; MONROE, KYLE D.; MUEHLEMANN, MICHAEL M.
To: SRX CARDIO, LLC
Reel/Frame 038448/0562 →
Assignment of Assignor's Interest
Dec 11, 2019
From: PORTOLA PHARMACEUTICALS, INC.
To: SRX CARDIO, LLC
Reel/Frame 051253/0245 →